Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Hologic, Inc.
  6. Summary
    HOLX   US4364401012

HOLOGIC, INC.

(HOLX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
75.97(c) 74.73(c) 73.06(c) 73.77(c) 73.94(c) Last
1 424 560 2 832 764 1 674 133 1 260 355 1 164 859 Volume
-1.12% -1.63% -2.23% +0.97% +0.23% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 3 953 M - -
Net income 2022 693 M - -
Net cash position 2022 158 M - -
P/E ratio 2022 27,0x
Yield 2022 -
Sales 2023 4 028 M - -
Net income 2023 735 M - -
Net cash position 2023 1 556 M - -
P/E ratio 2023 24,9x
Yield 2023 -
Capitalization 18 590 M 18 590 M -
EV / Sales 2022 4,66x
EV / Sales 2023 4,23x
Nbr of Employees 6 705
Free-Float 84,6%
More Financials
Company
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a range of diagnostics products, which are used primarily to aid in the... 
More about the company
Ratings of Hologic, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about HOLOGIC, INC.
11/30Hologic Closes on Acquisition of Bolder Surgical
BU
11/30Hologic Pledges to Donate $5 Million to Improve Women's Health, STEM Education and Soci..
BU
11/30Hologic Says Its COVID-19 Tests Can Detect Omicron Variant
MT
11/30Hologic, Inc. completed the acquisition of Bolder Surgical, LLC from Providence Venture..
CI
11/29Hologic's COVID-19 Tests Detect Omicron Variant
BU
11/29Hologic?s COVID-19 Tests Detect Omicron Variant
CI
11/23INSIDER SELL : Hologic
MT
11/23Hologic to Host Innovative Product Experiences and Medical Education Sessions On-site a..
BU
11/23Hologic, Inc. to Showcase its Extensive Portfolio of Breast and Skeletal Health Product..
CI
11/22Hologic to Webcast Presentation at Upcoming Virtual Investor Conference
BU
11/18Canada Ranks 43 out of 116 Countries and Territories on Women's Health
AQ
11/16HOLOGIC INC Management's Discussion and Analysis of Financial Condition and Results of..
AQ
11/04HOLOGIC INC : Change in Directors or Principal Officers, Financial Statements and Exhibits..
AQ
11/04Hologic Announces European Launch of Genius™ Digital Diagnostics System for Cervi..
BU
11/04Hologic Announces European Launch of Genius? Digital Diagnostics System for Cervical Ca..
CI
More news
News in other languages on HOLOGIC, INC.
11/01HOLOGIC : baisse des revenus et des bénéfices non GAAP au quatrième trimestre fiscal
11/01Earnings Flash (HOLX) HOLOGIC affiche un chiffre d'affaires de 1,32 milliard de dollars..
11/01GUIDANCE : (HOLX) HOLOGIC prévoit une fourchette d'EPS pour l'exercice 2022 de 3,55 à 3,85..
11/01GUIDANCE : (HOLX) HOLOGIC prévoit une fourchette de bénéfices par action pour le 1er trime..
11/01Hologic, Inc. fournit des prévisions de résultats pour le premier trimestre et l'année ..
More news
Analyst Recommendations on HOLOGIC, INC.
More recommendations
Chart HOLOGIC, INC.
Duration : Period :
Hologic, Inc. Technical Analysis Chart | HOLX | US4364401012 | MarketScreener
Technical analysis trends HOLOGIC, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 73,94 $
Average target price 84,33 $
Spread / Average Target 14,1%
EPS Revisions
Managers and Directors
Stephen P. MacMillan Chairman, President & Chief Executive Officer
Karleen Marie Oberton Chief Financial Officer
Jay A. Stein Chairman-Emeritus, Chief Technology Officer & SVP
Sally W. Crawford Lead Independent Director
Christiana Stamoulis Independent Director
Sector and Competitors
1st jan.Capi. (M$)
HOLOGIC, INC.1.52%18 590
THERMO FISHER SCIENTIFIC36.57%250 658
DANAHER CORPORATION40.88%223 620
INTUITIVE SURGICAL, INC.20.03%114 898
SIEMENS HEALTHINEERS AG52.50%80 761
EDWARDS LIFESCIENCES CORPORATION20.38%67 728